RT Journal Article
SR Electronic
T1 Stimulus-induced Gamma rhythms are weaker in human elderly with Mild Cognitive Impairment and Alzheimer’s Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.24.20139113
DO 10.1101/2020.06.24.20139113
A1 Murty, Dinavahi V. P. S.
A1 Manikandan, Keerthana
A1 Ramesh, Ranjini Garani
A1 Purokayastha, Simran
A1 Nagendra, Bhargavi
A1 Abhishek, M. L.
A1 Balakrishnan, Aditi
A1 Javali, Mahendra
A1 Rao, Naren Prahalada
A1 Ray, Supratim
YR 2020
UL http://medrxiv.org/content/early/2020/06/26/2020.06.24.20139113.abstract
AB Alzheimer’s Disease (AD) in elderly adds substantially to socio-economic burden necessitating early diagnosis. While recent studies in rodent models of AD have suggested diagnostic and therapeutic value for gamma rhythms in brain, the same has not been rigorously tested in humans. We recruited a large population (N=247; 106 females) of elderly (>49 years) individuals from the community, who viewed large gratings that induced strong gamma oscillations in their electroencephalogram (EEG). These individuals were classified as healthy (N=227), mild-cognitively-impaired (MCI; 14) or AD (6) based on clinical history and Clinical Dementia Rating scores. Surprisingly, stimulus-induced gamma rhythms, but not alpha or steady-state-visually-evoked-responses, were significantly lower in both MCI and AD patients compared to their age and gender matched controls. This reduction was not due to differences in eye movements or baseline power. Our results suggest that gamma could be used as potential diagnostic tool for MCI/AD in humans.One Sentence Summary A large double-blinded EEG study suggests that narrow-band visual gamma rhythms are weaker in MCI/AD patients compared to cognitively healthy controls.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCase-control studyFunding StatementThis work was supported by Tata Trusts Grant, Wellcome Trust/DBT India Alliance (Intermediate fellowship 500145/Z/09/Z and Senior fellowship IA/S/18/2/504003 to SR), and DBT-IISc Partnership Programme.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval given by Institute Human Ethics Committees of Indian Institute of Science, NIMHANS, and M S Ramaiah Hospital, Bangalore, IndiaAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe EEG data presented here is recorded as part of a large multi-investigator project that involved several other experiments and measurements like psychophysics, fMRI, PET, etc, some of which are still in progress. Hence, the data would be made available to readers upon request and publicly available at a later time, according to the policies of the project. All spectral analyses were performed using Chronux toolbox (version 2.10), available at http://chronux.org.